Trent G. Kamke - 07 Mar 2023 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Senior V. P., Operations
Signature
/s/ Val Gertz
Issuer symbol
LMAT
Transactions as of
07 Mar 2023
Net transactions value
+$100,012
Form type
4
Filing time
08 Mar 2023, 15:58:52 UTC
Previous filing
06 Mar 2023
Next filing
27 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $49,830 +1,592 +44% $31.30 5,209 07 Mar 2023 Direct F1
transaction LMAT Common Stock Options Exercise $47,308 +2,008 +39% $23.56 7,217 07 Mar 2023 Direct F1
transaction LMAT Common Stock Options Exercise $2,874 +81 +1.1% $35.48 7,298 07 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -1,592 -90% $0.000000 182 07 Mar 2022 Common Stock 1,592 $31.30 Direct F2
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -2,008 -33% $0.000000 4,018 07 Mar 2023 Common Stock 2,008 $23.56 Direct F3
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -81 -1.5% $0.000000 5,331 07 Mar 2023 Common Stock 81 $35.48 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2 This option is fully vested and exercisable.
F3 This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.